Dr. Vulliet's program was about the role of adult stem cells in treating canine diseases. His research has utilized primarily bone marrow stem cells to treat several cell-loss diseases such as Degenerative Myelopathy and Neuronal Ceroid Lipofuscinosis. He showed video of a first success in treating DM, a German Shepherd Dog named Turbo. Another success story was his treatment of Dilated Cardiomyopathy (DP) in a Doberman Pinscher named Gunner. Dr. Vulliet has treated four Tibetan Terriers with NCL. Three have shown definite improvement, and the fourth is likely improved.

In addition to speakers' seminar outlines, the printed program included written reports from 10 countries. Australia's report detailed their progress in forming a Tibetan Terrier “parent club”. Belgium, Canada, Denmark, Finland, Germany, Norway, Sweden, UK, and the United States also wrote reports about the TT and breeder population, organized club activities, and health statistics.

Late afternoon the World Congress meeting involved discussion of several topics. TT exhibitors and breeders discussed TTs being shown who are not typical of the written standard, and expressed that we need to communicate our objections to judges. The topic of changing the name of the breed from Tibetan Terrier to Tibetan Apso was posed, as our Tibetans are not true terriers. A question of making genetic testing mandatory for breeding was also brought to the Congress. New DNA tests for NCL and PLL in Tibetan Terriers are used by conscientious breeders all over the world. While other countries recommend testing, TT Clubs in only Belgium and Germany have required the testing of parents for litter registration.